Universal Vision Biotechnology Co Ltd

ROCO:3218 (Taiwan)  
NT$ 249.00 (-0.4%) Jun 21
20.22
P/B:
6.64
Market Cap:
NT$ 21.10B ($ 651.81M)
Enterprise V:
NT$ 20.23B ($ 625.16M)
Volume:
233.00K
Avg Vol (2M):
421.93K
Trade In:
Volume:
233.00K
Avg Vol (2M):
421.93K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Universal Vision Biotechnology Co Ltd ( ROCO:3218 ) from 2004 to Jun 21 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Universal Vision Biotechnology stock (ROCO:3218) PE ratio as of Jun 21 2024 is 20.22. More Details

Universal Vision Biotechnology Co Ltd (ROCO:3218) PE Ratio (TTM) Chart

To

Universal Vision Biotechnology Co Ltd (ROCO:3218) PE Ratio (TTM) Historical Data

Total 1224
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Universal Vision Biotechnology PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-21 20.2 2024-04-17 21.1
2024-06-20 20.3 2024-04-16 20.8
2024-06-19 20.2 2024-04-15 21.7
2024-06-18 20.5 2024-04-12 21.9
2024-06-17 20.2 2024-04-11 22.0
2024-06-14 20.3 2024-04-10 22.0
2024-06-13 20.0 2024-04-09 22.0
2024-06-12 20.1 2024-04-08 22.2
2024-06-11 20.1 2024-04-03 22.0
2024-06-07 20.7 2024-04-02 22.2
2024-06-06 20.3 2024-04-01 22.4
2024-06-05 20.5 2024-03-29 22.1
2024-06-04 20.1 2024-03-28 22.2
2024-06-03 20.2 2024-03-27 22.4
2024-05-31 20.1 2024-03-26 21.8
2024-05-30 20.0 2024-03-25 22.2
2024-05-29 20.6 2024-03-22 22.4
2024-05-28 20.7 2024-03-21 22.4
2024-05-27 20.8 2024-03-20 22.2
2024-05-24 20.7 2024-03-19 22.2
2024-05-23 20.7 2024-03-18 22.0
2024-05-22 20.9 2024-03-15 22.0
2024-05-21 21.1 2024-03-14 22.8
2024-05-20 21.8 2024-03-13 23.6
2024-05-17 21.1 2024-03-12 23.6
2024-05-16 20.9 2024-03-11 23.0
2024-05-15 20.7 2024-03-08 22.9
2024-05-14 20.9 2024-03-07 23.3
2024-05-13 21.4 2024-03-06 23.9
2024-05-10 21.0 2024-03-05 24.2
2024-05-09 20.1 2024-03-04 24.4
2024-05-08 20.5 2024-03-01 24.7
2024-05-07 20.8 2024-02-29 24.4
2024-05-06 20.4 2024-02-28 23.8
2024-05-03 20.6 2024-02-27 23.8
2024-05-02 20.8 2024-02-26 23.9
2024-04-30 20.8 2024-02-23 24.2
2024-04-29 21.0 2024-02-22 24.3
2024-04-26 19.5 2024-02-21 23.1
2024-04-25 19.5 2024-02-20 23.1
2024-04-24 19.9 2024-02-19 22.7
2024-04-23 19.8 2024-02-16 22.5
2024-04-22 19.2 2024-02-15 22.2
2024-04-19 20.0 2024-02-14 22.5
2024-04-18 20.7 2024-02-13 22.5

Universal Vision Biotechnology Co Ltd (ROCO:3218) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Universal Vision Biotechnology Co Ltd is mainly engaged in operating the business of (1) sales of optical devices, glasses, lens and other vision aid products (2) optometric services (3) sales and leasing of medical devices (4) providing of hospital management and technical consultancy services.